Payments to Acquire Property, Plant, and Equipment of HALOZYME THERAPEUTICS, INC. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
HALOZYME THERAPEUTICS, INC. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • HALOZYME THERAPEUTICS, INC. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $950,000, a 73% decline year-over-year.
  • HALOZYME THERAPEUTICS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $6,970,000, a 35% decline from 2024.
  • HALOZYME THERAPEUTICS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $10,696,000, a 30% decline from 2023.
  • HALOZYME THERAPEUTICS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $15,294,000, a 218% increase from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

HALOZYME THERAPEUTICS, INC. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $6,970,000 -$3,726,000 -35% 01 Jan 2025 31 Dec 2025 10-K 17 Feb 2026 2025 FY
2024 $10,696,000 -$4,598,000 -30% 01 Jan 2024 31 Dec 2024 10-K 17 Feb 2026 2025 FY
2023 $15,294,000 +$10,484,000 +218% 01 Jan 2023 31 Dec 2023 10-K 17 Feb 2026 2025 FY
2022 $4,810,000 +$3,353,000 +230% 01 Jan 2022 31 Dec 2022 10-K 18 Feb 2025 2024 FY
2021 $1,457,000 -$1,047,000 -42% 01 Jan 2021 31 Dec 2021 10-K 20 Feb 2024 2023 FY
2020 $2,504,000 -$1,536,000 -38% 01 Jan 2020 31 Dec 2020 10-K 21 Feb 2023 2022 FY
2019 $4,040,000 -$623,000 -13% 01 Jan 2019 31 Dec 2019 10-K 22 Feb 2022 2021 FY
2018 $4,663,000 +$3,313,000 +245% 01 Jan 2018 31 Dec 2018 10-K 23 Feb 2021 2020 FY
2017 $1,350,000 -$1,787,000 -57% 01 Jan 2017 31 Dec 2017 10-K 24 Feb 2020 2019 FY
2016 $3,137,000 +$777,000 +33% 01 Jan 2016 31 Dec 2016 10-K 21 Feb 2019 2018 FY
2015 $2,360,000 +$992,000 +73% 01 Jan 2015 31 Dec 2015 10-K 20 Feb 2018 2017 FY
2014 $1,368,000 -$929,000 -40% 01 Jan 2014 31 Dec 2014 10-K 28 Feb 2017 2016 FY
2013 $2,297,000 +$884,000 +63% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
2012 $1,413,000 +$584,492 +71% 01 Jan 2012 31 Dec 2012 10-K 02 Mar 2015 2014 FY
2011 $828,508 +$181,964 +28% 01 Jan 2011 31 Dec 2011 10-K 28 Feb 2014 2013 FY
2010 $646,544 01 Jan 2010 31 Dec 2010 10-K 01 Mar 2013 2012 FY

HALOZYME THERAPEUTICS, INC. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $950,000 -$2,595,000 -73% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q1 2024 $3,545,000 -$7,832,000 -69% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q1 2023 $11,377,000 +$10,887,000 +2222% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $490,000 +$220,000 +81% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q1 2021 $270,000 +$156,000 +137% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q1 2020 $114,000 -$813,000 -88% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q1 2019 $927,000 +$88,000 +10% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q1 2018 $839,000 +$740,000 +747% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019 2019 Q1
Q1 2017 $99,000 -$1,000,000 -91% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q1 2016 $1,099,000 +$969,000 +745% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q1 2015 $130,000 -$281,000 -68% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q1
Q1 2014 $411,000 -$123,000 -23% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015 2015 Q1
Q1 2013 $534,000 +$534,000 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014 2014 Q1
Q1 2012 $0 -$203,023 -100% 01 Jan 2012 31 Mar 2012 10-Q 08 May 2013 2013 Q1
Q1 2011 $203,023 01 Jan 2011 31 Mar 2011 10-Q 07 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.